4,475 followers
RT @BloodAdvances: A dual-expressor (MYC and BCL2) immunophenotype and TP53 alterations, but not MYC alterations, were significantly associ…
RT @BloodAdvances: A dual-expressor (MYC and BCL2) immunophenotype and TP53 alterations, but not MYC alterations, were significantly associ…
RT @BloodAdvances: A dual-expressor (MYC and BCL2) immunophenotype and TP53 alterations, but not MYC alterations, were significantly associ…
RT @BloodAdvances: A dual-expressor (MYC and BCL2) immunophenotype and TP53 alterations, but not MYC alterations, were significantly associ…
RT @BloodAdvances: A dual-expressor (MYC and BCL2) immunophenotype and TP53 alterations, but not MYC alterations, were significantly associ…